The Neurodegenerative Disease market was valued at approximately USD 39. 24 billion in 2020 and is expected to witness a revenue of USD 44. 90 billion in 2026, with a CAGR of 2. 30% over the forecast period. The Neurodegenerative Disease market was valued at approximately USD 39. 24 billion in 2020 and is expected to witness a revenue of USD 44. 90 billion in 2026, with a CAGR of 2. 30% over the forecast period.

By A Silva